Iceland· IS-IS/1/23/078/01

Navirel

A vinorelbine product containing vinorelbinum inn tvítartrat, registered in Iceland by medac Gesellschaft für klinische Spezialpräparate GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC L01CA04

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedNavirelATCL01CA04REGISTER NO.IS-IS/1/23/078/01PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Vinorelbine is registered in 18 of 19 countries.

Countries holding a registration under ATC L01CA04 (vinorelbine), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 11 of them publish a price we can compare per daily dose

Vinorelbine · ATC L01CA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinorelbine costs, country by country.

Normalised to the WHO defined daily dose (18 mg), the median price runs from $23.93 in France to $49.84 in Switzerland — a ×2.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vinorelbine · price per daily dose (18 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$49.84
  • IT Italy$38.71
  • FR France$23.93
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Vinorelbinum INN tvítartrat
Manufacturer
medac Gesellschaft für klinische Spezialpräparate GmbH
Country
Iceland (IS)
ATC code
L01CA04
ATC class
Vinorelbine
Defined daily dose
18 mg, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

536 interactions on record for vinorelbine.

Graded by severity as the source publishes them — 60 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vinorelbine · interactions on record

536 records

  • 60 severe
  • 307 moderate
  • 17 minor
  • 152 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinorelbine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinorelbine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Eberelbin, Navelbine
  • Belgium · Vinorelbin Eugia, Vinorelbine Accord Healthcare
  • Bulgaria · Винорелбин "ебеве"
  • Cyprus · Navirel, Vinorelbine Accord
  • Czechia · Navelbine, Navelbine Oral
  • Germany · Bendarelbin, Navelbine
  • Denmark · Navelbine, Navirel
  • Estonia · Navelbine, Vinorelbin Ebewe
  • Spain · Navelbine, Vinorelbina Accord
  • Finland · Navelbine, Vinorelbin Ebewe
  • France · Navelbine, Vinorelbine
  • United Kingdom (Northern Ireland) · Navelbine, Vinorelbine
  • Greece · Navelbine, Zaolin
  • Croatia · Vinorelsin
  • Hungary · Vinorelbin Sandoz
  • Ireland · Navelbine, Vinorelbine Accord
  • Italy · Navelbine, Vinorelbina Accord
  • Lithuania · Navelbine, Vinorelbin Ebewe
  • Luxembourg · Vinorelbin Ab, Vinorelbin Eugia
  • Latvia · Vinorelbine Accord
  • Malta · Vinorelbine Lotus, Vinorelbine Medac
  • Netherlands · Navelbine, Navirel
  • Norway · Navelbine, Navirel
  • Poland · Navelbine, Navirel
  • Portugal · Navelbine, Vinorrelbina
  • Romania · Navelbine, Vinorelbin Teva
  • Sweden · Navelbine, Navirel
  • Slovenia · Vinorelbin Accord, Vinorelbin Sandoz
  • Slovakia · Navelbine, Navelbine Oral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8352fe94-e369-4245-af9b-e6855fa26185
GET /v1/drugs/8352fe94-e369-4245-af9b-e6855fa26185?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innrennslisþykkni, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "L01CA04",
  "marketed": false,
  "strength": "10 mg/ml",
  "ma_number": "IS/1/23/078/01",
  "substance": "Vinorelbinum INN tvítartrat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "45117"
}

See everything about vinorelbine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.